Angiotensinogen (1-14) (human) (trifluoro<wbr/>acetate salt)

Angiotensinogen (1-14) (human) (trifluoroacetate salt)

CAT N°: 24989
Price:

74.00 62.90

Angiotensinogen (1-14), also known as tetradecapeptide (TDP), is a synthetic peptide precursor of angiotensin I (Item No. 24737) that corresponds to amino acids 1-14 of endogenous human angiotensinogen.{42045} Angiotensinogen (1-14) is cleaved by renin at the Leu-Val peptide bond to release angiotensin I, which is then converted to angiotensin II (Item No. 17150) by angiotensin converting enzyme (ACE) and exerts vasoconstrictive properties.{42047} Angiotensinogen (1-14) (0.001-1 ?M) induces contraction of isolated rat femoral resistance vessels, an effect that is reduced by the angiotensin II receptor partial antagonist saralasin and enhanced by the serine protease kallikrein.{42046}

Territorial Availability: Available through Bertin Technologies only in France

  • Synonyms
    • L-?-aspartyl-L-arginyl-L-valyl-L-tyrosyl-L-isoleucyl-L-histidyl-L-prolyl-L-phenylalanyl-L-histidyl-L-leucyl-L-valyl-L-isoleucyl-L-histidyl-L-asparagine, trifluoroacetate salt
  • Correlated keywords
    • 104180-23-6 tetra-deca-peptide renin substrate
  • Product Overview:
    Angiotensinogen (1-14), also known as tetradecapeptide (TDP), is a synthetic peptide precursor of angiotensin I (Item No. 24737) that corresponds to amino acids 1-14 of endogenous human angiotensinogen.{42045} Angiotensinogen (1-14) is cleaved by renin at the Leu-Val peptide bond to release angiotensin I, which is then converted to angiotensin II (Item No. 17150) by angiotensin converting enzyme (ACE) and exerts vasoconstrictive properties.{42047} Angiotensinogen (1-14) (0.001-1 ?M) induces contraction of isolated rat femoral resistance vessels, an effect that is reduced by the angiotensin II receptor partial antagonist saralasin and enhanced by the serine protease kallikrein.{42046}

We also advise you